These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35413401)

  • 1. The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression.
    Wang G; Duan J; Pu G; Ye C; Li Y; Xiu W; Xu J; Liu B; Zhu Y; Wang C
    Biochim Biophys Acta Mol Basis Dis; 2022 Aug; 1868(8):166413. PubMed ID: 35413401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression.
    Schulien I; Hockenjos B; Schmitt-Graeff A; Perdekamp MG; Follo M; Thimme R; Hasselblatt P
    Cell Death Differ; 2019 Sep; 26(9):1688-1699. PubMed ID: 30778201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
    Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK
    Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis.
    Zhu C; Kim K; Wang X; Bartolome A; Salomao M; Dongiovanni P; Meroni M; Graham MJ; Yates KP; Diehl AM; Schwabe RF; Tabas I; Valenti L; Lavine JE; Pajvani UB
    Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice.
    Du M; Wang X; Yuan L; Liu B; Mao X; Huang D; Yang L; Huang K; Zhang F; Wang Y; Luo X; Wang C; Peng J; Liang M; Huang D; Huang K
    J Hepatol; 2020 Dec; 73(6):1333-1346. PubMed ID: 32717288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.
    Syn WK; Choi SS; Liaskou E; Karaca GF; Agboola KM; Oo YH; Mi Z; Pereira TA; Zdanowicz M; Malladi P; Chen Y; Moylan C; Jung Y; Bhattacharya SD; Teaberry V; Omenetti A; Abdelmalek MF; Guy CD; Adams DH; Kuo PC; Michelotti GA; Whitington PF; Diehl AM
    Hepatology; 2011 Jan; 53(1):106-15. PubMed ID: 20967826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
    Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
    Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis.
    Feng Y; Li W; Wang Z; Zhang R; Li Y; Zang L; Wang P; Li Z; Dong Y
    J Transl Med; 2022 Nov; 20(1):497. PubMed ID: 36324154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic osteopontin signaling by CREBZF defines a checkpoint for steatosis-to-NASH progression.
    Ma F; Liu Y; Hu Z; Xue Y; Liu Z; Cai G; Su W; Zheng Z; Fang X; Yan X; Ding D; Sun X; Jiang Y; Wei S; Li W; Zhao J; Zhang H; Li H; Xiao D; Zhang C; Ying H; Qin J; Gao X; Dai X; Fu W; Xu Y; Li Y; Cui A
    Hepatology; 2023 Nov; 78(5):1492-1505. PubMed ID: 36680394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease.
    Wu H; Zhou M; Jin Q; Wang X; Xu Y; Li M; Chen S; Tang Q; Wang Q; Hu B; Wu H; Xiao M; Qu L; Zhang Q; Liu J
    Hepatol Int; 2024 Aug; 18(4):1144-1157. PubMed ID: 38184503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor CCR1 regulates macrophage activation through mTORC1 signaling in nonalcoholic steatohepatitis.
    Li H; Pan T; Gao L; Ding R; Yu Y; Ma M; Wang Y; Jin S; Chen Y; Ding C; Xu L
    Metabolism; 2024 Feb; 151():155758. PubMed ID: 38070823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis.
    Zhang X; Li S; Zhou Y; Su W; Ruan X; Wang B; Zheng F; Warner M; Gustafsson JÅ; Guan Y
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3181-3185. PubMed ID: 28270609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model.
    Thapaliya S; Wree A; Povero D; Inzaugarat ME; Berk M; Dixon L; Papouchado BG; Feldstein AE
    Dig Dis Sci; 2014 Jun; 59(6):1197-206. PubMed ID: 24795036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis.
    Gao Y; Liu Y; Yang M; Guo X; Zhang M; Li H; Li J; Zhao J
    Oncotarget; 2016 Jun; 7(23):33649-61. PubMed ID: 27172901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-derived Osteopontin (SPP1) Protects From Nonalcoholic Steatohepatitis.
    Han H; Ge X; Komakula SSB; Desert R; Das S; Song Z; Chen W; Athavale D; Gaskell H; Lantvit D; Guzman G; Nieto N
    Gastroenterology; 2023 Jul; 165(1):201-217. PubMed ID: 37028770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch/osteopontin signaling.
    Li Y; Xiu W; Xu J; Chen X; Wang G; Duan J; Sun L; Liu B; Xie W; Pu G; Wang Q; Wang C
    JCI Insight; 2022 Dec; 7(23):. PubMed ID: 36477358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study on roles of natural killer T cells in two diet-induced non-alcoholic steatohepatitis-related fibrosis in mice.
    Zheng S; Yang W; Yao D; Tang S; Hou J; Chang X
    Ann Med; 2022 Dec; 54(1):2233-2245. PubMed ID: 35950602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.